Canadian healthcare capacity gaps for disease-modifying treatment in Huntington’s disease: a survey of current practice and modelling of future needs

OBJECTIVES: Disease-modifying therapies in development for Huntington’s disease (HD) may require specialised administration and additional resource capacity. We sought to understand current and future capacity for HD management in Canada considering the possible introduction of an intrathecal (IT) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bénard, Angèle, Chouinard, Sylvain, Leavitt, Blair R, Budd, Nathalie, Wu, Jennifer W, Schoffer, Kerrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161103/
https://www.ncbi.nlm.nih.gov/pubmed/35649593
http://dx.doi.org/10.1136/bmjopen-2022-062740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161103/
https://www.ncbi.nlm.nih.gov/pubmed/35649593
http://dx.doi.org/10.1136/bmjopen-2022-062740

Ejemplares similares